Stuart M. Langbein
Stuart Langbein brings a passion for healthcare to his office each day. He is renowned for his leadership in facilitating the market viability of new medical technologies, and knows how to develop and implement strategies that secure their coverage, coding, and reimbursement.
When clients work with Stuart, they quickly learn about the importance of being proactive. That's especially critical for organizations with new medical technologies; Stuart is often advising them long before they're granted Food and Drug Administration approval.
Stuart routinely works with a cross-section of medical technology organizations, including pharmaceutical, biological, and medical device companies; trade associations, and academic medical centers. He continues to build on his prior experience at the Centers for Medicare & Medicaid Services, as well as on his long-term relationships with many agency officials.
Stuart is a longstanding volunteer for the JDRF, an international organization focused on a cure for diabetes. He coordinates the Hogan Lovells Walk to Cure Diabetes team, and works on national government advocacy issues related to diabetes.
Secured coding and Medicare payment for new mammography technology.
Assisted a medical device company in the reversal of Medicare non-coverage of artificial hearts, and secured an inpatient new technology add-on.
Helped multiple clients obtain Healthcare Common Procedure Coding System code for their products and prompt reimbursement for the products.
Assisted organ procurement organizations with their membership in the United Network for Organ Sharing and participation in the Medicare program.
Facilitated obtaining Medicare coverage of Investigation Device Exemption devices.
Represented hospital associations in a challenge to a Medicare outpatient hospital rule that resulted in a favorable administrative resolution.